Lenacapavir, a twice yearly injection that prevents HIV transmission, was named the breakthrough medicine of 2024. But without US foreign aid dollars, its delivery to millions worldwide is under ...

KZN’s top women researcher believes a game changer is around the corner. It needs political will and no geopolitical head winds ...

Two-year-old Evans was brought to the Nyumbani Children’s Home in Nairobi, Kenya a year ago, suffering from HIV and ...

The U.S. President's Emergency Plan for AIDS Relief (PEPFAR) contributed US$15.6 million to the HIV response in Ukraine during 2023 and 2024. This includes $11 million for antiretroviral therapy and ...

A multi-national, multi-institutional study investigators found little natural resistance to a new HIV therapy called lenacapavir in a population of patients in Uganda.

According to the definitions of the Life Cycle Initiative,13 the foreground system consists ... to the previously published LCA results for the TMC114FD1HTX1002 phase 1 HIV trial, we see some more ...

A multi-national, multi-institutional study led by Weill Cornell Medicine investigators found little natural resistance to a ...

A multi-national, multi-institutional study led by Weill Cornell Medicine investigators found little natural resistance to a ...

Supercomputer simulations have revealed how changes in the shape of the HIV-1 capsid protein may help the virus squeeze its ...

VICTORIA — Antiretroviral treatment has increased the life expectancy of people living with HIV in British Columbia but a new study shows it is significantly lower for women than men.

The far-reaching move could disrupt U.S. programs around the world, including a widely lauded effort to combat HIV worldwide that is credited with saving some 25 million lives, U.S. officials warned.